Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management
Morie A. Gertz
Hematology
Research output
:
Contribution to journal
›
Article
›
peer-review
31
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Waldenstrom Macroglobulinemia
100%
Risk Management
80%
Immunoglobulin M
32%
Rituximab
26%
carfilzomib
19%
Bendamustine Hydrochloride
18%
PCI 32765
18%
Purine Nucleosides
17%
Lenalidomide
16%
Everolimus
15%
Thalidomide
15%
Bortezomib
14%
Alkylating Agents
14%
Nucleosides
12%
Stem Cell Transplantation
12%
Lymphadenopathy
12%
Natural History
12%
Disease Management
12%
Therapeutics
11%
Platelet Count
11%
Bone Marrow Cells
11%
Thrombocytopenia
11%
Cyclophosphamide
11%
Dexamethasone
11%
Anemia
10%
Lymphoma
10%
Hemoglobins
9%
Proteins
8%
Mutation
6%